Literature DB >> 8027548

Inhibition of Plasmodium falciparum in vitro by human gamma delta T cells.

M M Elloso1, H C van der Heyde, J A vande Waa, D D Manning, W P Weidanz.   

Abstract

As assessed by flow cytometry, human gamma delta T cells were shown here to inhibit replication of blood-stage Plasmodium falciparum in vitro in a dose-dependent fashion; no other leukocyte population tested was suppressive. Replication of intraerythrocytic stages of the parasite (rings, trophozoites, and schizonts) was not affected by coculture with gamma delta T cells nor were erythrocytes damaged by this coculture, indicating that the targets recognized by gamma delta T cells are extracellular merozoites in transit to new host erythrocytes. Moreover, parasite inhibition requires contact between gamma delta T cells and merozoites. These findings suggest that gamma delta T cells may exert a protective effect in immunity to malaria.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027548

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

1.  Rhoptry-associated protein 1-binding monoclonal antibody raised against a heterologous peptide sequence inhibits Plasmodium falciparum growth in vitro.

Authors:  R Moreno; F Pöltl-Frank; D Stüber; H Matile; M Mutz; N A Weiss; G Pluschke
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Enhancement of dendritic cell activation via CD40 ligand-expressing γδ T cells is responsible for protective immunity to Plasmodium parasites.

Authors:  Shin-Ichi Inoue; Mamoru Niikura; Satoru Takeo; Shoichiro Mineo; Yasushi Kawakami; Akihiko Uchida; Shigeru Kamiya; Fumie Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

3.  Splenic gammadelta T cells regulated by CD4+ T cells are required to control chronic Plasmodium chabaudi malaria in the B-cell-deficient mouse.

Authors:  Henri C van der Heyde; Joan M Batchelder; Matyas Sandor; William P Weidanz
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

4.  Cord blood Vγ2Vδ2 T cells provide a molecular marker for the influence of pregnancy-associated malaria on neonatal immunity.

Authors:  Cristiana Cairo; Nyaradzo Longinaker; Giulia Cappelli; Rose G F Leke; Manuel Mve Ondo; Rosine Djokam; Josephine Fogako; Robert J Leke; Bertrand Sagnia; Samuel Sosso; Vittorio Colizzi; C David Pauza
Journal:  J Infect Dis       Date:  2013-12-10       Impact factor: 5.226

5.  Murine gamma delta T lymphocytes elicited during Plasmodium yoelii infection respond to Plasmodium heat shock proteins.

Authors:  J Kopacz; N Kumar
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

6.  Gamma delta T-cell function in pathogenesis of cerebral malaria in mice infected with Plasmodium berghei ANKA.

Authors:  D M Yañez; J Batchelder; H C van der Heyde; D D Manning; W P Weidanz
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 7.  Recognition of nonpeptide antigens by T cells.

Authors:  Y Tanaka; M B Brenner; B R Bloom; C T Morita
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

8.  The response of gamma delta T cells to Plasmodium falciparum is dependent on activated CD4+ T cells and the recognition of MHC class I molecules.

Authors:  S M Jones; M R Goodier; J Langhorne
Journal:  Immunology       Date:  1996-11       Impact factor: 7.397

9.  γδ T Cells Kill Plasmodium falciparum in a Granzyme- and Granulysin-Dependent Mechanism during the Late Blood Stage.

Authors:  Maria Andrea Hernández-Castañeda; Katharina Happ; Filippo Cattalani; Alexandra Wallimann; Marianne Blanchard; Isabelle Fellay; Brigitte Scolari; Nils Lannes; Smart Mbagwu; Benoît Fellay; Luis Filgueira; Pierre-Yves Mantel; Michael Walch
Journal:  J Immunol       Date:  2020-02-17       Impact factor: 5.422

Review 10.  Direct microbicidal activity of cytotoxic T-lymphocytes.

Authors:  Paul Oykhman; Christopher H Mody
Journal:  J Biomed Biotechnol       Date:  2010-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.